Left atrial appendage closure device with anti-thrombogenic covering
Medical devices as wells as methods for making and using medical devices are disclosed. An example medical device may include a left atrial appendage device. The left atrial appendage device may include an expandable frame configured to shift between a first configuration and an expanded configuration. A fabric mesh may be disposed along at least a portion of the expandable frame. An anti-thrombogenic coating may be disposed along the fabric mesh.
1. A left atrial appendage device, comprising:
an expandable frame configured to shift between a first configuration and an expanded configuration;
a fabric mesh disposed along at least a portion of the expandable frame;
an anti-thrombogenic coating disposed along the fabric mesh;
wherein the fabric mesh includes a plurality of filaments;
wherein the plurality of filaments are arranged into a fiber bundle; and
wherein the anti-thrombogenic coating migrates to an interior region of the fiber bundle.
2. The left atrial appendage device of claim 1 , wherein the plurality of filaments include polyethylene terephthalate.
3. The left atrial appendage device of claim 1 , wherein the plurality of filaments include polyester.
4. The left atrial appendage device of claim 1 , wherein the anti-thrombogenic coating encapsulates at least some of the plurality of filaments.
5. The left atrial appendage device of claim 1 , wherein the anti-thrombogenic coating individually coats each of the plurality of filaments.
6. The left atrial appendage device of claim 1 , wherein the plurality of filaments are arranged in a non-woven configuration.
7. The left atrial appendage device of claim 1 , wherein the anti-thrombogenic coating includes a fluoropolymer.
8. The left atrial appendage device of claim 1 , wherein the anti-thrombogenic coating includes polyvinylidene fluoride.
9. The left atrial appendage device of claim 1 , wherein the anti-thrombogenic coating includes a polyvinylidene fluoride copolymer.
10. The left atrial appendage device of claim 1 , wherein the anti-thrombogenic coating includes poly(vinylidene fluoride-co-hexafluoropropylene).
11. The left atrial appendage device of claim 1 , wherein the anti-thrombogenic coating includes poly[bis (trifluoroethoxy)phosphazene].
12. A left atrial appendage device, comprising: an expandable framework configured to shift between a delivery configuration and a deployed configuration; wherein the expandable framework is configured to engage a left atrial appendage when in the deployed configuration; a fabric disposed along at least a portion of the expandable framework, the fabric including one or more knitted fiber bundles; wherein each of the one or more knitted fiber bundles include a plurality of filaments; and an anti-thrombogenic coating disposed along each of the plurality of filaments that migrates to an interior region of the knitted fiber bundle.
13. The left atrial appendage device of claim 12 , wherein the anti-thrombogenic coating encapsulates each of the plurality of filaments.
14. The left atrial appendage device of claim 12 , wherein the anti-thrombogenic coating includes a fluoropolymer.
15. The left atrial appendage device of claim 12 , wherein the anti-thrombogenic coating includes poly(vinylidene fluoride-co-hexafluoropropylene).
16. An occlusive medical device, comprising: an expandable frame configured to shift between a delivery configuration and an expanded configuration; wherein the expandable frame is configured to be implanted adjacent to a left atrial appendage; a fabric mesh disposed along at least a portion of the expandable frame, the fabric mesh including one or more fiber bundles arranged into a pattern; wherein each of the one or more fiber bundles include a plurality of filaments; an anti-thrombogenic coating disposed along each of the plurality of filaments that migrates to an interior region of the one or more fiber bundles; and wherein at least one of the one or more fiber bundles includes an interior region and wherein a section of the anti-thrombogenic coating is disposed along the interior region.
17. The occlusive medical device of claim 16 , wherein the anti-thrombogenic coating encapsulates each of the plurality of filaments.